Stay updated on Intratumoral TAK-981 Microdosing in Head and Neck Cancer Clinical Trial
Sign up to get notified when there's something new on the Intratumoral TAK-981 Microdosing in Head and Neck Cancer Clinical Trial page.

Latest updates to the Intratumoral TAK-981 Microdosing in Head and Neck Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.8%
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check33 days agoChange DetectedThe web page has been updated to reflect a modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference1%
- Check61 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check76 days agoChange DetectedThe page has been updated to reflect new information regarding the evaluation of TAK-981 in combination with cetuximab and avelumab for head and neck cancer, including the addition of collaborators and a revision update. The previous detailed description of the study's methodology has been removed.SummaryDifference34%
- Check83 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
Stay in the know with updates to Intratumoral TAK-981 Microdosing in Head and Neck Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Intratumoral TAK-981 Microdosing in Head and Neck Cancer Clinical Trial page.